Chandrasekhar Bal

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Ejection Fraction

Combination Therapy

Computed Tomography

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Sivasankar Kanankulam Velliangiri, Sanjana Ballal, Madhav Prasad Yadhav, Madhavi Tripathi, Swayamjeet Satapathy, Chandrasekhar Bal
A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases. PloS one 18 (11) (2023)
Swayamjeet Satapathy, Althaf K Majeed, Sanjana Ballal, Chandrasekhar Bal
Appropriateness of 14-year cutoff in pediatric differentiated thyroid cancer: Comparison of clinical characteristics and long-term outcomes in 14 years and younger and 15-18 years age groups. Pediatric blood & cancer (2023)
Madhav Prasad Yadav, Sanjana Ballal, Ranjit Kumar Sahoo, Madhavi Tripathi, Nishikant Avinash Damle, Shamim Ahmed Shamim, Rakesh Kumar, Amlesh Seth, Chandrasekhar Bal
Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients. PloS one 16 (5) (2021)
Sanjana Ballal, Madhav P Yadav, Ranjit K Sahoo, Madhavi Tripathi, Sada N Dwivedi, Chandrasekhar Bal
225 Ac-PSMA-617-targeted alpha therapy for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. The Prostate 81 (9) (2021)